Market Closed

ORKA
Oruka Therapeutics
$ 105.35
0.34%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago

Oruka Therapeutics News

Latest Oruka Therapeutics Stock News & ORKA Headlines

Oruka Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update
5 days ago | globenewswire.com
Oruka Therapeutics, Inc. $ORKA Stock: Candriam S.C.A. Lowers Holdings
6 days ago | defenseworld.net
Oruka Therapeutics to Participate in Multiple Upcoming Conferences
12 days ago | globenewswire.com
Oruka's ORKA-001 Delivers 61% Complete Skin Clearance in Phase IIb Psoriasis Study
19 days ago | marketbeat.com
Oruka Therapeutics, Inc. (ORKA) Discusses Interim EVERLAST-B Results for ORCA 001 in Plaque Psoriasis Transcript
19 days ago | seekingalpha.com
Oruka Therapeutics Novel Biologic Outperforms Placebo in Psoriasis Trial
19 days ago | benzinga.com
Oruka Therapeutics Announces Positive Week 16 Results for ORKA-001 from the Ongoing EVERLAST-B Trial in Moderate-to-Severe Psoriasis
20 days ago | globenewswire.com
Oruka Therapeutics to Host Conference Call to Report Week 16 Data for ORKA-001 from the Ongoing EVERLAST-B Trial on October 26, 2026
20 days ago | globenewswire.com
Oruka Therapeutics: The Psoriasis Market Is Becoming A Barbell, And ORKA-001 Owns The Far End
a month ago | seekingalpha.com
ORKA Stock Down 5% Despite Positive Week 28 Psoriasis Efficacy Data
2 months ago | zacks.com
Load More

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

oinCodex Android App
CoinCodex Mobile App
Market Closed

ORKA
Oruka Therapeutics
$ 105.35
0.34%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago